Los Angeles Capital Management’s Stemline Therapeutics, Inc. STML Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-85,805
| Closed | -$415K | – | 1548 |
|
|
2020
Q1 | $415K | Buy |
85,805
+48,470
| +130% | +$234K | ﹤0.01% | 964 |
|
|
2019
Q4 | $397K | Buy |
37,335
+4,630
| +14% | +$49.2K | ﹤0.01% | 1069 |
|
|
2019
Q3 | $340K | Buy |
32,705
+21,540
| +193% | +$224K | ﹤0.01% | 1095 |
|
|
2019
Q2 | $171K | Hold |
11,165
| – | – | ﹤0.01% | 1301 |
|
|
2019
Q1 | $143K | Sell |
11,165
-2,160
| -16% | -$27.7K | ﹤0.01% | 1327 |
|
|
2018
Q4 | $127K | Sell |
13,325
-175
| -1% | -$1.67K | ﹤0.01% | 1233 |
|
|
2018
Q3 | $224K | Sell |
13,500
-11,320
| -46% | -$188K | ﹤0.01% | 1306 |
|
|
2018
Q2 | $398K | Buy |
+24,820
| New | +$398K | ﹤0.01% | 1200 |
|